These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25398788)

  • 41. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
    Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
    Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TDAG51 induces renal interstitial fibrosis through modulation of TGF-β receptor 1 in chronic kidney disease.
    Carlisle RE; Mohammed-Ali Z; Lu C; Yousof T; Tat V; Nademi S; MacDonald ME; Austin RC; Dickhout JG
    Cell Death Dis; 2021 Oct; 12(10):921. PubMed ID: 34625532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
    Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
    Liu Z; Huang XR; Lan HY
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F986-97. PubMed ID: 22237801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
    Peters H; Border WA; Noble NA
    Kidney Int; 2000 Apr; 57(4):1493-501. PubMed ID: 10760085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TGFβ receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells.
    Chen G; Chen X; Sukumar A; Gao B; Curley J; Schnaper HW; Ingram AJ; Krepinsky JC
    J Cell Sci; 2013 Aug; 126(Pt 16):3697-712. PubMed ID: 23781022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.
    Hao J; Liu S; Zhao S; Liu Q; Lv X; Chen H; Niu Y; Duan H
    Histochem Cell Biol; 2011 Feb; 135(2):173-81. PubMed ID: 21240525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles.
    Yellaturu CR; Deng X; Cagen LM; Wilcox HG; Mansbach CM; Siddiqi SA; Park EA; Raghow R; Elam MB
    J Biol Chem; 2009 Mar; 284(12):7518-32. PubMed ID: 19158095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.
    Morales MG; Abrigo J; Meneses C; Simon F; Cisternas F; Rivera JC; Vazquez Y; Cabello-Verrugio C
    Clin Sci (Lond); 2014 Aug; 127(4):251-64. PubMed ID: 24588264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TGF-β1 downregulates AT1 receptor expression via PKC-δ-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-γ association with KLF4.
    Zhang XH; Zheng B; Gu C; Fu JR; Wen JK
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1015-23. PubMed ID: 22282354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of SREBP With Fatostatin Does Not Attenuate Early Diabetic Nephropathy in Male Mice.
    Van Krieken R; Marway M; Parthasarathy P; Mehta N; Ingram AJ; Gao B; Krepinsky JC
    Endocrinology; 2018 Mar; 159(3):1479-1495. PubMed ID: 29420703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
    Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
    Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
    Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
    Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
    Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells.
    Rodríguez-Barbero A; Dorado F; Velasco S; Pandiella A; Banas B; López-Novoa JM
    Kidney Int; 2006 Sep; 70(5):901-9. PubMed ID: 16820791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect and mechanism of the Ang-(1-7) on human mesangial cells injury induced by low density lipoprotein.
    Huang W; Tang L; Cai Y; Zheng Y; Zhang L
    Biochem Biophys Res Commun; 2014 Jul; 450(2):1051-7. PubMed ID: 24978313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. G
    Parichatikanond W; Duangrat R; Mangmool S
    Eur J Pharmacol; 2023 Jul; 951():175780. PubMed ID: 37209939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New EGFR inhibitor, 453, prevents renal fibrosis in angiotensin II-stimulated mice.
    Skibba M; Qian Y; Bao Y; Lan J; Peng K; Zhao Y; Zhong P; Hu J; Li X; Liang G
    Eur J Pharmacol; 2016 Oct; 789():421-430. PubMed ID: 27497883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis.
    Du X; Kristiana I; Wong J; Brown AJ
    Mol Biol Cell; 2006 Jun; 17(6):2735-45. PubMed ID: 16571675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.
    Peters H; Border WA; Noble NA
    Kidney Int; 1998 Nov; 54(5):1570-80. PubMed ID: 9844133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.